Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200045/S020

RelayPro Thoracic Stent-Graft System

Bolton Medical, Inc. · Decision date Sep 10, 2025

FDA DECISIONP200045/S020

What did the FDA decide?

FDA records P200045/S020 as a supplement to PMA P200045, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 10, 2025.

FDA approval order statement

removal of a coating to a delivery system component and an update to the in-process quality inspection of delivery system of the RelayPro Thoracic Stent-Graft System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 10, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P200045/S020
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
OK30
Decision date
Sep 10, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

For the original device and its historical approval scope, see PMA P200045. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200045 · Original PMA

    RelayPro Thoracic Stent-Graft System

  2. P200045/S016 · Related supplement

    RelayPro Thoracic Stent-Graft System

  3. P200045/S020 received

    Application receipt date recorded by FDA.

  4. P200045/S020 · FDA decision

    30-Day Notice

  5. P200045/S018 · Related supplement

    RelayPro Thoracic Stent-Graft System

  6. P200045/S022 · Related supplement

    RelayPro Thoracic Stent-Graft System

  7. P200045/S017 · Related supplement

    RelayPro Thoracic Stent-Graft System

  8. P200045/S024 · Related supplement

    RelayPro Thoracic Stent-Graft System

  9. P200045/S025 · Related supplement

    RelayPro Thoracic Stent-Graft Delivery System

Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200045

Product / regulatory recordCompanyPathwayDecision dateSource
Bolton Medical, Inc.PMA approvalAug 5, 2021FDA
Bolton Medical, Inc.PMA supplementJul 22, 2025FDA
RelayProP200045/S019
Bolton Medical, Inc.PMA supplementSep 3, 2025FDA
Bolton Medical, Inc.PMA supplementOct 7, 2025FDA
Bolton Medical, Inc.PMA supplementFeb 19, 2026FDA
Bolton Medical, Inc.PMA supplementApr 13, 2026FDA
Bolton Medical, Inc.PMA supplementJun 18, 2026FDA
Bolton Medical, Inc.PMA supplementOct 28, 2026FDA

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bolton Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
799 International Pkwy., Sunrise, FL, 33325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records